Top Cited Articles

We are delighted to share the 2019 impact factor for the International Journal of Gynecological Cancer of 2.095 (Journal Citation Reports, Clarivate Analytics), which ranked 41/82 in the Obstetrics and Gynecology category and 195/244 in the Oncology category.

The quality and impact of our journals are dependent on many different measures. We’ve provided here some of those metrics for International Journal of Gynecological Cancer, to reflect the latest 2019 data, that remain important to our authors. We’ve also listed our top most cited articles from each of the last two years, free to read.


Guidelines for perioperative care in gynecologic/oncology: Enhanced Recovery After Surgery (ERAS) Society recommendations—2019 update
MARCH 2019 10.1136/ijgc-2019-000356

Laparoscopic radical hysterectomy with transvaginal closure of vaginal cuff – a multicenter analysis
JUNE 2019 10.1136/ijgc-2019-000388

SENTICOL III: an international validation study of sentinel node biopsy in early cervical cancer. A GINECO, ENGOT, GCIG and multicenter study
MAY 2019 10.1136/ijgc-2019-000332

A prospective multicenter trial on sentinel lymph node biopsy in patients with early-stage cervical cancer (SENTIX)
JANUARY 2019 10.1136/ijgc-2018-000010

Impact of micrometastasis or isolated tumor cells on recurrence and survival in patients with early cervical cancer: SENTICOL Trial
MARCH 2019 10.1136/ijgc-2018-000089

The first Japanese nationwide multicenter study of BRCA mutation testing in ovarian cancer: CHARacterizing the cross-sectionaL approach to Ovarian cancer geneTic TEsting of BRCA (CHARLOTTE)
JULY 2019 10.1136/ijgc-2019-000384

ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease
MAY 2019 10.1136/ijgc-2019-000308

TRUST: Trial of Radical Upfront Surgical Therapy in advanced ovarian cancer (ENGOT ov33/AGO-OVAR OP7)
OCTOBER 2019 10.1136/ijgc-2019-000682

Clinical application of the sentinel lymph node technique in early ovarian cancer: a pilot study
FEBRUARY 2019 10.1136/ijgc-2018-000049

Association of metformin use with ovarian cancer incidence and prognosis: a systematic review and meta-analysis
JANUARY 2019 10.1136/ijgc-2018-000060


The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients With Cervical Cancer
MAY 2018 10.1097/IGC.0000000000001216

Comparison of Different Surgical Approaches for Stage IB1 Cervical Cancer Patients: A Multi-institution Study and a Review of the Literature
JUNE 2018 10.1097/IGC.0000000000001254

A Randomized Phase 2 Study of ADXS11-001 Listeria monocytogenes-Listeriolysin O Immunotherapy With or Without Cisplatin in Treatment of Advanced Cervical Cancer
MAY 2018 DOI: 10.1097/IGC.0000000000001235

Endometrial Cancers Harboring Mutated Fibroblast Growth Factor Receptor 2 Protein Are Successfully Treated With a New Small Tyrosine Kinase Inhibitor in an Orthotopic Mouse Model
JANUARY 2018 10.1097/IGC.0000000000001129

Quality of Life in Women After Pelvic Exenteration for Gynecological Malignancies A Multicentric Study
FEBRUARY 2018 10.1097/IGC.0000000000000612

Chemoresistance of Gastric-Type Mucinous Carcinoma of the Uterine Cervix: A Study of the Sankai Gynecology Study Group
JANUARY 2018 10.1097/IGC.0000000000001145

The Role of Radiotherapy in Extramammary Paget Disease: A Systematic Review
MAY 2018 DOI: 10.1097/IGC.0000000000001237

The LACC Trial: Has Minimally Invasive Surgery for Early-Stage Cervical Cancer Been Dealt a Knockout Punch?
SEPTEMBER 2018 10.1097/IGC.0000000000001342

Surgical Treatment of Early-Stage Cervical Cancer: A Multi-Institution Experience in 2124 Cases in The Netherlands Over a 30-Year Period
MAY 2018 10.1097/IGC.0000000000001228

Prophylactic Extended-Field Irradiation for Patients With Cervical Cancer Treated With Concurrent Chemoradiotherapy: A Propensity-Score Matching Analysis
OCTOBER 2018 10.1097/IGC.0000000000001344

Journal Metrics:

Days to first decision: 16
Days from acceptance to publication: 29

2 year Impact Factor (JCR): 2.095
SciMago Journal Rank (SJR): 1.011
Eigenfactor: 0.01217
Citescore: 3.8

2019 total Content accesses: 310,000
Altmetric score: 2,688